Patents by Inventor David A. Borror

David A. Borror has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for reducing the incidence of necrotizing enterocolitis
    Patent number: 6306908
    Abstract: Enteral formulas that contain long-chain polyunsaturated fatty acids (PUFAs), e.g., arachidonic acid (AA), and docosahexaenoic acid (DHA), essentially free of cholesterol, are described for use in methods for reducing the incidence of necrotizing enterocolitis. Compositions from egg yolk lipids are preferred as they contain &ohgr;-6 and &ohgr;-3 long chain PUFAs and are predominantly in a phosphtidylcholine form. This is believed to provide a synergetic effect.
    Type: Grant
    Filed: May 12, 2000
    Date of Patent: October 23, 2001
    Assignee: Abbott Laboratories
    Inventors: Susan E. Carlson, Debra L. Ponder, Michael B. Montalto, Margaret H. Dohnalek, John D. Benson, David A. Borror, David V. Diodato
  • Methods for reducing the incidence of necrotizing enterocolitis
    Patent number: 6080787
    Abstract: Enteral formulas that contain long-chain polyunsaturated fatty acids (PUFAs), as arachidonic acid (AA) and docosahexaenoic acid (DHA) that are essentially free of cholesterol, are described. More particularly, the invention relates to methods for reducing the incidence of necrotizing enterocolitis by administering compositions which provide .omega.-6 and .omega.-3 long chain PUFAs, phospholipids and/or choline. Compositions from egg yolk lipids are presently preferred as they contain .omega.-6 and .omega.-3 long chain PUFAs and are predominantly in a phosphtidylcholine form. This is believed to provide a synergistic effect.
    Type: Grant
    Filed: October 3, 1997
    Date of Patent: June 27, 2000
    Assignee: Abbott Laboratories
    Inventors: Susan E. Carlson, Debra L. Ponder, Michael B. Montalto, Margaret H. Dohnalek, John D. Benson, David A. Borror, David V. Diodato
  • Process of making an enteral formula containing long-chain polyunsaturated fatty acids
    Patent number: 6036992
    Abstract: Enteral formulas that contain long-chain polyunsaturated fatty acids (PUFAs) and a process for making such enteral compositions are described. More particularly, the invention relates to enteral compositions which provide long chain PUFAs arachidonic acid (AA) and docosahexaenoic acid (DHA) essentially free of cholesterol and may be derived from egg yolk lipids, and thus are predominantly in a phospholipid form. The process of making such a composition provides improved organoleptic and stability properties. Enteral compositions according to this invention may be used to feed infants, particularly pre-term infants, to promote neural development and development of visual acuity, and to reduce the incidence of necrotizing enterocolitis.
    Type: Grant
    Filed: March 16, 1999
    Date of Patent: March 14, 2000
    Assignee: Abbott Laboratories
    Inventors: David A. Borror, David V. Diodato, Debra L. Ponder, Margaret H. Dohnalek